GSK and Lyell to collaborate on cancer cell therapies

GSK and Lyell Immunopharma have announced a five-year collaboration to develop new technologies with the aim of improving cell therapies for cancer patients. In the announcement the companies explained that the collaboration will apply Lyell’s technologies to further strengthen GSK’s cell therapy pipeline, including GSK3377794, which targets the NY-ESO-1 antigen that is expressed across multiple

Continue Reading

Novartis and Microsoft join together to transform medicine using AI

Novartis and Microsoft have announced a new collaboration with the aim to “transform medicine with artificial intelligence.” Novartis announced the “important step in reimagining medicine” by founding the Novartis AI innovation lab, choosing Microsoft as its strategic AI and data-science partner. The company says that the new lab will look to bolster Novartis AI capabilities

Continue Reading

University of Andrews opens earlier diagnosis institute

The University has established a new institute to obtain earlier diagnosis of cancer, cardiovascular disease, mental health and infection and help address current inequalities. Early diagnosis is critical in order to achieve the best treatment outcomes, yet diseases are much more likely to be diagnosed earlier in affluent areas compared to Scotland’s most deprived communities.

Continue Reading

Oxford Biomedica and Santen sign ophthalmology R&D deal

UK biotech Oxford Biomedica and Japanese Santen have begun an option and licence agreement to research and develop gene therapy products for an inherited retinal disease. Inherited retinal diseases are a group of rare disorders caused by one of more than 260 different genes where mutation results in vision loss or blindness, often disproportionally affecting

Continue Reading

UK scientists find new compound that kills antibiotic-resistant superbugs

A new compound which visualises and kills antibiotic resistant superbugs has been discovered by scientists at the University of Sheffield and Rutherford Appleton Laboratory (RAL). A team led by Professor Jim Thomas, from the University of Sheffield’s Department of Chemistry, is testing new compounds developed by his PhD student Kirsty Smitten, on antibiotic resistant gram-negative

Continue Reading